Mammary Cell News Volume 14.06 | Feb 17 2022

    0
    44







    2022-02-17 | MCN 14.06


    Mammary Cell News by STEMCELL Technologies
    Vol. 14.06 – 17 February, 2022
    TOP STORY

    Lin28B-High Breast Cancer Cells Promote Immune Suppression in the Lung Pre-Metastatic Niche via Exosomes and Support Cancer Progression

    Researchers demonstrated that Lin28B promoted lung metastasis of breast cancer by building an immune-suppressive pre-metastatic niche.
    [Nature Communications]

    Full Article
    How to prioritize and manage your research projects
    PUBLICATIONSRanked by the impact factor of the journal

    LGL1 Binds to Integrin β1 and Inhibits Downstream Signaling to Promote Epithelial Branching in the Mammary Gland

    Scientists demonstrated that Lgl1 modulation of Integrin β1 signaling was essential for directional migration and that epithelial branching in invertebrates and the mammary gland was fundamentally distinct.
    [Cell Reports]

    Full ArticleGraphical Abstract

    CircKDM4B Suppresses Breast Cancer Progression via the miR-675/NEDD4L Axis

    CircKDM4B inhibited migration and tube formation of human umbilical vein endothelial cells in vitro and angiogenesis in vivo.
    [Oncogene]

    Abstract

    Fascin Enhances the Vulnerability of Breast Cancer to Erastin-Induced Ferroptosis

    The authors investigated the expression profiles and biological effects of fascin actin-bundling protein 1 (Fascin) in breast cancer.
    [Cell Death & Disease]

    Full Article

    Regulation of P53 Signaling in Breast Cancer by the E3 Ubiquitin Ligase RNF187

    Investigators reported that RNF187, a RING family ubiquitin ligase, facilitated breast cancer growth and inhibited apoptosis by modulating P53 signaling.
    [Cell Death & Disease]

    Full Article

    Trastuzumab/Pertuzumab Combination Therapy Stimulates Anti-tumor Responses through Complement-Dependent Cytotoxicity and Phagocytosis

    Researchers identified that only Trastuzumab+Pertuzumab combination therapy, but not when either antibody used in isolation, allowed for the activation of the classical complement pathway, resulting in both direct complement-dependent cytotoxicity as well as complement-dependent cellular phagocytosis of HER2+ breast cancer cells.
    [JCI Insight]

    AbstractFull ArticleGraphical Abstract

    Long Noncoding RNA CCAT2 Reduces Chemosensitivity to 5-Fluorouracil in Breast Cancer Cells by Activating the mTOR Axis

    The authors explored whether breast cancer cell drug sensitivity to 5-Fluorouracil was related to lncRNA CCAT2-regulated mTOR pathway.
    [Journal of Cellular and Molecular Medicine]

    Full Article

    EGFR Ligand Clustering on E2 Bionanoparticles for Targeted Delivery of Chemotherapeutics to Breast Cancer Cells

    Researchers demonstrated approximately 3-fold higher doxorubicin internalization in inflammatory breast cancer cells compared to healthy breast epithelial cells, leading to targeted cell death at concentrations below the IC50 of free doxorubicin.
    [Journal of the American Chemical Society]

    AbstractGraphical Abstract

    Dual Targeting Micelles Loaded with Paclitaxel and Lapatinib for Combinational Therapy of Brain Metastases from Breast Cancer

    Angiopep-2 had high loading efficiency of paclitaxel and lapatinib could transport across the in vitro blood–brain barrier model and accumulate in breast cancer cells.
    [Scientific Reports]

    Full Article

    Serotoninergic Receptor Ligands Improve Tamoxifen Effectiveness on Breast Cancer Cells

    The authors investigated the effect of 10 serotoninergic receptor ligands on viability of MCF7, SKBR3 and MDA-MB231 breast cancer cells and focused on their potential ability to affect Tamoxifen responsiveness in ER+ cells.
    [BMC Cancer]

    Full Article
    Subscribe to Science News for free weekly science newsletters.
    REVIEWS

    Recent Advances of Transcriptomics and Proteomics in Triple-Negative Breast Cancer Prognosis Assessment

    Scientists review the recent progress of TNBC research in transcriptomics and proteomics to identify possible therapeutic goals and improve the survival of patients with TNBC.
    [Journal of Cellular and Molecular Medicine]

    Full Article

    Cytotoxic Mechanisms of Doxorubicin at Clinically Relevant Concentrations in Breast Cancer Cells

    The authors provide insight into the mechanistic pathway(s) of doxorubicin at levels found within patients and establish the magnitude of effect for each mechanism.
    [Cancer Chemotherapy and Pharmacology]

    Abstract
    INDUSTRY AND POLICY NEWS

    Paige and Mindpeak Announce Partnership to Expand Access to Industry – Leading AI Software for Breast Cancer

    Paige and Mindpeak announced a distribution partnership, which will enable pathologists to use Mindpeak’s BreastIHC within the Paige Platform. Mindpeak’s BreastIHC is an AI software that reliably and accurately detects, classifies and quantifies breast cancer cells.
    [Paige AI]

    Press Release
    FEATURED EVENT

    EMBO: Microbial Infections and Human Cancer

    April 6 – 9, 2022
    Heidelberg, Germany

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Position – Biomolecular NMR

    University of Vienna – Vienna, Austria

    Postdoctoral Fellow – Cancer Biology

    Icahn School of Medicine at Mount Sinai – New York, New York, United States

    Postdoctoral Positions – Molecular Cancer Research

    University of Copenhagen – Copenhagen, Denmark

    Postdoctoral Fellows – Cancer Research

    The Wistar Institute – Philadelphia, Pennsylvania, United States

    Pathologist – Surgical Cases

    Brigham and Women’s Hospital – Boston, Massachusetts, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Mammary Cell News Twitter